pHLS-EF1a-FRB-SpCas9-A Citations (1)

Originally described in: Extracellular nanovesicles for packaging of CRISPR-Cas9 protein and sgRNA to induce therapeutic exon skipping.
Gee P, Lung MSY, Okuzaki Y, Sasakawa N, Iguchi T, Makita Y, Hozumi H, Miura Y, Yang LF, Iwasaki M, Wang XH, Waller MA, Shirai N, Abe YO, Fujita Y, Watanabe K, Kagita A, Iwabuchi KA, Yasuda M, Xu H, Noda T, Komano J, Sakurai H, Inukai N, Hotta A Nat Commun. 2020 Mar 13;11(1):1334. doi: 10.1038/s41467-020-14957-y. PubMed Journal

---

Articles Citing pHLS-EF1a-FRB-SpCas9-A

Articles
Delivery of engineered extracellular vesicles with miR-29b editing system for muscle atrophy therapy. Chen R, Yuan W, Zheng Y, Zhu X, Jin B, Yang T, Yan Y, Xu W, Chen H, Gao J, Li G, Gokulnath P, Vulugundam G, Li J, Xiao J. J Nanobiotechnology. 2022 Jun 27;20(1):304. doi: 10.1186/s12951-022-01508-4. PubMed

If you have published an article using this material, please email us at to have your article added to this page.